Software at the heart of the matter
Sally CroftPharmaceutical companies spend millions developing new drugs but around half of all candidates never make it to market because they are discovered to have an adverse effect on the human heart. The most common problem is arrhythmia – abnormal beating – which can occasionally prove fatal, so pharmaceutical regulators demand strict testing standards and clinical trials before new medicines are released. Even then, a significant number of drugs are subsequently withdrawn because of previously undetected side effects. Researchers at the[...]